Government funding for RNA research extendedThe German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) has extended funding for the "Transregio" Collaborative Research Center "Non-coding RNA in the cardiovascular system" (TRR 267). The research project is being led by Technical University of Munich (TUM). In addition, two new projects for which TUM was an applicant university have been approved in the fields of quantum technology and medicine.
Since 2019 the Collaborative Research Center (CRC) "Non-coding RNA in the cardiovascular system" has been examining the role these nucleic acids play in the emergence and cure of cardio-vascular disease. Spokesperson of TRR 267 is Stefan Engelhardt , Professor of Pharmacology and Toxicology at TUM. The DFG has now announced that the project will receive funding for an additional four years.
The DFG’s Collaborative Research Centers are among the most important research funding programs in Germany. They enable demanding, interdisciplinary and long-term research projects. The DFG approves the CRCs for an initial period of four years, with a maximum possible funding period of twelve years. A "Transregio" is a Collaborative Research Center whose partners collaborate across regional boundaries.
New Transregios with TUM participationTRR 353: Regulation of Cell Death Decisions
Cell death processes are just as important to the development and survival of animals and humans as the growth and reproduction of cells is. This CRC focuses on the mechanistic processes in the decision on life or death of the cell. The objective is to understand, predict and influence this decision.
TRR 360: Constrained Quantum Matters (ConQuMat)
This Collaborative Research Center is working to influence the properties of quantum materials and to discover new phenomena and effects. In the long term the research alliance’s work will provide tie-ins for quantum technological applications, for example in quantum information technology.